Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539

OBJECTIVE(S): This is the first clinical outcomes report of NRG Oncology RTOG 0539, detailing the primary endpoint, 3-year progression-free survival (3yPFS), compared to a predefined historical control for intermediate-risk meningioma, and secondarily evaluating overall survival (OS), local failure,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosurg
Main Authors: Rogers, Leland, Zhang, Peixin, Vogelbaum, Michael A., Perry, Arie, Ashby, Lynn S., Modi, Jignesh M., Alleman, Anthony M., Galvin, James, Brachman, David, Jenrette, Joseph M., De Groot, John, Bovi, Joseph A., Werner-Wasik, Maria, Knisely, Jonathan P. S., Mehta, Minesh P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889346/
https://ncbi.nlm.nih.gov/pubmed/28984517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.11.JNS161170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados